TCBP News and Press, TC BioPharm (Holdings) plc From 04/04/24

TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies PR Newswire EDINBURGH, Scotland , April 4, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage b...

2024-04-02 09:05:48 ET More on TC Biopharm TCBP announces exercise of series D warrants for cash TC BioPharm to slash 50% of workforce in cost saving effort Financial information for TC Biopharm Read the full article on Seeking Alpha For further detai...

TCBP Increasing Treatment Capacity with Expanded Manufacturing Process PR Newswire Developing streamlined approach to reduce cost per patient by 85% EDINBURGH, Scotland , April 2, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "...

2024-03-20 08:17:57 ET More on premarket gainers & stock Topgolf Callaway Brands: Cheap Valuation Relative To Peers Post Earnings Topgolf Callaway Brands Corp. (MODG) Q4 2023 Earnings Call Transcript Topgolf Callaway Brands Corp. 2023 Q4 - Results - Earnings Call...

TCBP Adjourns General Meeting Until a Later Date PR Newswire EDINBURGH, Scotland , March 19, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...

2024-03-18 10:00:18 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Johnson & Johnson, Boston...

2024-03-18 09:09:07 ET More on TC Biopharm TC BioPharm to slash 50% of workforce in cost saving effort Financial information for TC Biopharm Read the full article on Seeking Alpha For further details see: TCBP announces exercise of series D warrants for cash

TCBP Announces Exercise of Series D Warrants For Cash PR Newswire •  Company receives gross proceeds of $1.26 M from transaction EDINBURGH, Scotland , March 18, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (...

2024-03-12 12:21:11 ET More on Mid-day movers & stocks. FibroGen, Inc. 2023 Q4 - Results - Earnings Call Presentation FibroGen, Inc. (FGEN) Q4 2023 Earnings Call Transcript Lexaria to test DehydraTECH GLP-1 product for weight loss, diabetes Lexaria slips ...

2024-03-12 10:00:37 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...